Page last updated: 2024-10-24

histone mRNA catabolic process

Definition

Target type: biologicalprocess

The chemical reactions and pathways resulting in the breakdown of histone messenger RNA (mRNA). [GOC:dgf, GOC:krc, PMID:17179095, PMID:17855393]

Histone mRNA catabolic process is a tightly regulated process that ensures the rapid degradation of histone mRNAs in response to cellular demands. This process is crucial for maintaining proper chromatin structure and gene expression. Here's a detailed breakdown:

**1. Initiation:**
* Histone mRNAs are typically transcribed in large quantities during the S phase of the cell cycle, when DNA replication occurs.
* The transcription of histone genes is regulated by a variety of factors, including the availability of transcription factors and the presence of specific DNA elements.

**2. Processing and Translation:**
* Histone mRNAs undergo limited processing, including capping and polyadenylation. This is unlike most other mRNAs, which undergo extensive splicing and other modifications.
* They are translated into histone proteins, which are critical components of nucleosomes, the fundamental building blocks of chromatin.

**3. Rapid Degradation:**
* Histone mRNAs have a very short half-life, typically only a few minutes. This rapid degradation is essential for maintaining proper histone levels and preventing excessive accumulation of histones.
* The degradation of histone mRNAs is initiated by the recruitment of a specific deadenylation complex, which removes the poly(A) tail from the 3' end of the mRNA.
* Following deadenylation, the mRNA is rapidly degraded by a complex of enzymes, including the exosome and the 5'-3' exonuclease Xrn1.
* This process ensures that histone mRNA levels are tightly controlled and that there is a rapid response to changes in cellular demands for histones.

**4. Regulation:**
* The degradation of histone mRNAs is regulated by a variety of factors, including the availability of transcription factors, the presence of specific DNA elements, and the cellular environment.
* For instance, during periods of cell growth and proliferation, histone mRNA degradation is suppressed to allow for the production of large amounts of histones.
* Conversely, during cell cycle arrest or differentiation, histone mRNA degradation is increased to reduce histone levels.

**5. Significance:**
* The histone mRNA catabolic process plays a crucial role in maintaining genome integrity, regulating gene expression, and controlling cell growth and proliferation.
* Disruptions in this process can lead to various cellular abnormalities, including cancer and developmental defects.

**Key Enzymes and Factors Involved:**
* Deadenylation Complex
* Exosome
* Xrn1
* Histone mRNA-specific factors (e.g., SLBP, CAF-1)

**Overall, the histone mRNA catabolic process is a finely tuned mechanism that ensures proper histone levels and contributes to the stability and regulation of the genome.**'
"

Proteins (1)

ProteinDefinitionTaxonomy
Serine-protein kinase ATMA serine-protein kinase ATM that is encoded in the genome of human. [PRO:CNA]Homo sapiens (human)

Compounds (20)

CompoundDefinitionClassesRoles
pd 173074aromatic amine;
biaryl;
dimethoxybenzene;
pyridopyrimidine;
tertiary amino compound;
ureas
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first sourcechromones;
morpholines;
organochlorine compound
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
schizandrin bschizandrin B: a phytogenic antineoplastic agent with anti-inflammatory activity; isolated from Schisandra plant
thioureathiourea : The simplest member of the thiourea class, consisting of urea with the oxygen atom substituted by sulfur.

Thiourea: A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.
one-carbon compound;
thioureas;
ureas
antioxidant;
chromophore
ku 559332-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one: specific inhibitor of the ataxia-telangiectasia mutated kinase ATM; structure in first source
cgk 733diarylmethane
nu 70262-(morpholin-4-yl)benzo(h)chromen-4-one: a radiosensitizing agent that inhibits DNA-dependent protein kinase; structure in first sourceorganic heterotricyclic compound;
organooxygen compound
nu 74418-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one: structure in first sourcedibenzothiophenes
ku-0060648dibenzothiophenes
dactolisibdactolisib : An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment.

dactolisib: antineoplastic agent that inhibits both phosphatidylinositol 3-kinase and mTOR
imidazoquinoline;
nitrile;
quinolines;
ring assembly;
ureas
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
ku 60019
cp 466722quinazolines
(3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)-4-pyrimidinyl]-3-methylmorpholineindoles
ve 8213-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide: an antineoplastic agent; structure in first sourcearomatic amide
torin 2torin 2 : A member of the class of pyridoquinolines that is benzo[h][1,6]naphthyridin-2-one carrying additional 3-(trifluoromethyl)phenyl and 6-aminopyridin-3-yl substituents at positions 1 and 9 respectively. It is a potent inhibitor of mTOR and exhibits anti-cancer properties.aminopyridine;
organofluorine compound;
primary amino compound;
pyridoquinoline
antineoplastic agent;
mTOR inhibitor
byl719proline derivative
cc-1151-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one: an mTOR kinase inhibitor; structure in first source
vx-970berzosertib: an ATR kinase inhibitorsulfonamide
etp-46464ETP-46464: inhibits ATM and Rad3-related kinase; structure in first source